Therapeutic Apheresis and Dialysis · 2014 · 11 citations · 17 references
MedicineMolecular MedicineNephrologyDialysisHemodialysisRenal Replacement TherapyCardiovascular DiseaseChronic Kidney DiseaseMicrorna BiologyMicrorna-mediated RegulationRenal DiseaseBlood LipidsCardiovascular Disease MortalityCirculating MicrornasContinuous HemodialysisInflammation In HemodialysisInflammatory Responses To HemodialysisMicrorna BiomarkersMicrorna In Inflammation
Atherosclerosis and accompanying cardiovascular disease are the first causes of mortality in patients undergoing maintenance hemodialysis. Anti-atherosclerotic effects of hemodiafiltration (HDF) have been reported. Our study aimed to investigate the effect of serum derived from a healthy group (n = 23), before and after hemodialysis (HD) therapy (n = 23), and before and after HDF therapy (n = 17) on the expression of microRNA-33a and its target genes adenosine triphosphate-binding cassette transporter A1,G1 (ABCA1, ABCG1) in THP-1 macrophages. Meanwhile, blood lipids and high-sensitivity C-reactive protein (hs-CRP) were measured in these groups. Our data showed that the expression of miRNA-33a was lower (P < 0.05) and ABCA1 and ABCG1 were higher (P < 0.05) in the healthy group than pre-HD and pre-HDF. miR-33a was significantly decreased (P < 0.05) but ABCA1, ABCG1 was significantly increased (P < 0.05) in post-HDF compared with pre-HDF, while these parameters in pre- and post- HD groups did not show any significant change (P > 0.05). High density lipoprotein cholesterol (HDL-C) was higher and hs-CRP was lower in the healthy group than pre-HD and pre-HDF groups. Moreover, a significant increase of HDL-C (P < 0.05) and decrease (P < 0.05) of hs-CRP was shown in post-HDF compared with pre-HDF, but HD appeared to have no significant change in these subjects. HDF therapy can downregulate miR-33a expression, and then result in ABCA1, ABCG1 upregulation and an increase in circulating HDL-C, leading to a possible anti-atherosclerosis effect to some extent.
17
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
Christoph Wanner, Vera Krane, Winfried März et al. · New England Journal of Medicine · 2005 · 2.6K citations · Full text
Colin Baigent, Martin Landray, Christina Reith et al. · The Lancet · 2011 · 2.5K citations
MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
Katey J. Rayner, Yajaira Suárez, Alberto Dávalos et al. · Science · 2010 · 1.2K citations · Full text
MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis
S. Hani Najafi‐Shoushtari, Fjoralba Kristo, Yingxia Li et al. · Science · 2010 · 938 citations